Myfortic

Myfortic

mycophenolic acid

Manufacturer:

Novartis Healthcare

Distributor:

Zuellig
Concise Prescribing Info
Contents
Mycophenolic acid
Indications/Uses
Prophylaxis of acute transplant rejection in patients receiving allogeneic renal transplants in combination w/ ciclosporin for microemulsion & corticosteroids.
Dosage/Direction for Use
720 mg bid (1,440 mg daily dose). In patients receiving 2 g mycophenolate mofetil, treatment can be replaced by 720 mg bid (1,440 mg daily dose).
Administration
May be taken with or without food: Swallow whole, do not chew/crush.
Contraindications
Hypersensitivity to mycophenolate Na, mycophenolic acid or mycophenolate mofetil.
Special Precautions
Not to be used in patients w/ hereditary deficiency of hypoxanthine-guanine phosphoribosyl-transferase. Increased risk of developing lymphomas & other malignancies particularly of the skin. Over-suppression of the immune system w/ increased susceptibility to infection. Viral reactivation in patients infected w/ HBV or HCV; monitor patients infected w/ hepatitis B or C for clinical & lab signs of active HBV or HCV infection. Risk of progressive multifocal leukoencephalopathy & pure red cell aplasia. Patients w/ active serious digestive system disease. Report any sign of bone marrow depression. Perform CBC on a regular basis. Avoid live-attenuated vaccines. Male patient should use condoms &/or partner should use highly effective contraception. Not to be used during pregnancy & lactation. Childn.
Adverse Reactions
Viral, bacterial & fungal infections; leukopenia; hypocalcemia, hypokalemia, hyperuricemia; HTN; diarrhea. Upper resp tract infection, pneumonia; anemia, thrombocytopenia; hyperkalemia, hypomagnesemia; anxiety; dizziness, headache; aggravated HTN, hypotension; cough, dyspnea, exertional dyspnea; abdominal distension/pain, constipation, dyspepsia, flatulence, gastritis, loose stools, nausea, vomiting; abnormal hepatic function tests; arthralgia, asthenia, myalgia; increased blood creatinine; fatigue, peripheral edema, pyrexia.
Drug Interactions
Not recommended in concomitant use w/ azathioprine, live vaccines. Increased plasma conc w/ aciclovir. Decreased absorption w/ Mg & Al hydroxide antacids; ganciclovir. Tacrolimus. Potential to reduce efficacy w/ cholestyramine or drugs that interfere w/ enterohepatic circulation. OC's.
MIMS Class
Immunosuppressants
ATC Classification
L04AA06 - mycophenolic acid ; Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.
Presentation/Packing
Form
Myfortic gastro-resistant tab 360 mg
Packing/Price
120's (P83/pack)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in